BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu K, Wang Y, Wan T, Zhai Y, Cao S, Ruan W, Wu C, Xu Y. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. Int J Nanomedicine 2018;13:129-42. [PMID: 29317821 DOI: 10.2147/IJN.S150319] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Cláudia Paiva-santos A, Gama M, Peixoto D, Sousa-oliveira I, Ferreira-faria I, Zeinali M, Abbaspour-ravasjani S, Mascarenhas-melo F, Hamishehkar H, Veiga F. Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis. International Journal of Pharmaceutics 2022;618:121656. [DOI: 10.1016/j.ijpharm.2022.121656] [Reference Citation Analysis]
2 Camargo GDA, Costa Filha ARCD, Lyra AM, Novatski A, Nadal JM, de Lara LS, Dias DT, Nascimento EAD, Rocha Silva U, Jacinto C, Farago PV. Stability testing of tacrolimus-loaded poly(ԑ-caprolactone) nanoparticles by physicochemical assays and Raman spectroscopy. Vibrational Spectroscopy 2020;110:103139. [DOI: 10.1016/j.vibspec.2020.103139] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Hemrajani C, Negi P, Parashar A, Gupta G, Jha NK, Singh SK, Chellappan DK, Dua K. Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. Biomed Pharmacother 2022;147:112633. [PMID: 35030434 DOI: 10.1016/j.biopha.2022.112633] [Reference Citation Analysis]
4 Fereig SA, El-Zaafarany GM, Arafa MG, Abdel-Mottaleb MMA. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis. Drug Deliv 2020;27:662-80. [PMID: 32393082 DOI: 10.1080/10717544.2020.1754527] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
5 Zeng Z, Huang Q, Mao L, Wu J, An S, Chen Z, Zhang W. The Pyruvate Dehydrogenase Complex in Sepsis: Metabolic Regulation and Targeted Therapy. Front Nutr 2021;8:783164. [PMID: 34970577 DOI: 10.3389/fnut.2021.783164] [Reference Citation Analysis]
6 Parekh K, Mehta TA, Dhas N, Kumar P, Popat A. Emerging Nanomedicines for the Treatment of Atopic Dermatitis. AAPS PharmSciTech 2021;22:55. [PMID: 33486609 DOI: 10.1208/s12249-021-01920-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Fereig SA, El-Zaafarany GM, Arafa MG, Abdel-Mottaleb MMA. Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis. Int J Pharm 2021;608:121114. [PMID: 34543618 DOI: 10.1016/j.ijpharm.2021.121114] [Reference Citation Analysis]
8 Magnifico I, Petronio Petronio G, Venditti N, Cutuli MA, Pietrangelo L, Vergalito F, Mangano K, Zella D, Di Marco R. Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? Pharmaceuticals (Basel) 2020;13:E411. [PMID: 33266440 DOI: 10.3390/ph13110411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Camargo GDA, Ferreira L, Schebelski DJ, Lyra AM, Barboza FM, Carletto B, Koga AY, Semianko BC, Dias DT, Lipinski LC, Novatski A, Raman V, Manfron J, Nadal JM, Farago PV. Characterization and In Vitro and In Vivo Evaluation of Tacrolimus-Loaded Poly(ε-Caprolactone) Nanocapsules for the Management of Atopic Dermatitis. Pharmaceutics 2021;13:2013. [PMID: 34959295 DOI: 10.3390/pharmaceutics13122013] [Reference Citation Analysis]
10 Yadav K, Soni A, Singh D, Singh MR. Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies. Prog Biomater 2021;10:1-17. [PMID: 33738750 DOI: 10.1007/s40204-021-00154-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wollina U, Tirant M, Vojvodic A, Lotti T. Treatment of Psoriasis: Novel Approaches to Topical Delivery. Open Access Maced J Med Sci 2019;7:3018-25. [PMID: 31850114 DOI: 10.3889/oamjms.2019.414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Wang Y, Cao S, Yu K, Yang F, Yu X, Zhai Y, Wu C, Xu Y. Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects. Int J Nanomedicine 2019;14:5849-63. [PMID: 31440050 DOI: 10.2147/IJN.S212260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Souto EB, Dias-Ferreira J, Oliveira J, Sanchez-Lopez E, Lopez-Machado A, Espina M, Garcia ML, Souto SB, Martins-Gomes C, Silva AM. Trends in Atopic Dermatitis-From Standard Pharmacotherapy to Novel Drug Delivery Systems. Int J Mol Sci 2019;20:E5659. [PMID: 31726723 DOI: 10.3390/ijms20225659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
14 Damiani G, Eggenhöffner R, Pigatto PDM, Bragazzi NL. Nanotechnology meets atopic dermatitis: Current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature. Bioact Mater 2019;4:380-6. [PMID: 31872162 DOI: 10.1016/j.bioactmat.2019.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]